Holen Sie sich die Stockscreener-App
83.75
0.41%
-0.3457
Schlusskurs vom Vortag:
$84.10
Offen:
$83.23
24-Stunden-Volumen:
133.20K
Relative Volume:
0.08
Marktkapitalisierung:
$14.25B
Einnahmen:
$8.28B
Nettoeinkommen (Verlust:
$1.43B
KGV:
10.26
EPS:
8.1642
Netto-Cashflow:
$-203.00M
1W Leistung:
-4.25%
1M Leistung:
+9.20%
6M Leistung:
+10.28%
1J Leistung:
+16.18%
1-Tages-Spanne:
$82.25
$83.90
1-Wochen-Bereich:
$81.22
$90.00
52-Wochen-Spanne:
$62.38
$90.00
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
83.73 | 14.32B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
402.12 | 141.75B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
180.44 | 49.41B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
73.18 | 36.42B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.34 | 32.61B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.26 | 30.74B | 29.14B | 1.07B | 1.05B | 1.1956 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-24 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum Corp. stock falls Tuesday, underperforms market - marketwatch.com
SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook - Yahoo! Finance Canada
Solventum Corporation (SOLV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Solventum Corporation (SOLV) stock price, news, quote and history - Yahoo Finance UK
Solventum Corporation (SOLV) Stock Forecasts - Yahoo! Finance Canada
Solventum Doubles Down on Medtech and Plans to Separate Healthcare Information Systems - Morningstar
Solventum Corp. stock rises Monday, outperforms market - marketwatch.com
Solventum Corporation (SOLV) Stock Analysis: Exploring Potential Upside with a 13.19% Gain Insight - DirectorsTalk Interviews
Solventum (SOLV) Stock May Trade At A Discount After 13% Gain - simplywall.st
Janus Henderson Group PLC Buys 21,094 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans - finance.yahoo.com
Solventum Q2 Earnings Call Highlights - MarketBeat
Solventum Corporation (NYSE:SOLV) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Solventum (NYSE:SOLV) Upgraded at Wall Street Zen - MarketBeat
Solventum Nears Inflection Point As It Begins to Unlock Value - MarketBeat
Solventum Corp (SOLV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Solventum (SOLV) Stock Retreats As Tariff Refund Clouds Underlying Growth - simplywall.st
Solventum Corp stock hits 52-week high at 89.35 USD By Investing.com - Investing.com Australia
Solventum Corp. stock falls Thursday, underperforms market - marketwatch.com
Solventum Announces Intent to Separate Health Information Systems Business - HIT Consultant
Solventum to Spin Off Health IT Unit After 3M Split - Medical Device and Diagnostic industry
Solventum (NYSE:SOLV) Given New $105.00 Price Target at Piper Sandler - MarketBeat
Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates - finance.yahoo.com
Solventum Eyes Spin Or Sale Of Health IT Unit As 3M Split Nears End, Raises Full-Year Guidance - insights.citeline.com
Solventum Corporation Stock 12‑Month Price Target Raised to $95, Implies 9% Upside - TradingView
Wedbush Raises Solventum (NYSE:SOLV) Price Target to $101.00 - MarketBeat
Jefferies & Co. Adjusts Solventum Price Target to $95 From $79 - marketscreener.com
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Solventum (NYSE:SOLV) Reaches New 1-Year High on Earnings Beat - MarketBeat
Solventum Corp stock hits 52-week high at 89.35 USD - Investing.com
Solventum plans software separation to become ‘true medtech company’ - MedTech Dive
Stifel Nicolaus Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price - MarketBeat
Solventum Corporation Q2 2026 Earnings Call Summary - finance.yahoo.com
Royal Bank of Canada Has $22.68 Million Stock Holdings in Solventum Corporation $SOLV - MarketBeat
What Solventum (SOLV)'s Earnings Beat And Health IT Spinoff Plan Means For Shareholders - simplywall.st
Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ... - finance.yahoo.com
Solventum Corp Provides Information the Shareholders - marketscreener.com
Solventum (SOLV) Q2 2026 Earnings Call Transcript - Fortune
Solventum to hive off healthcare software business, raises profit forecast - 101 WIXX
Solventum Corporation 2026 Q2ResultsEarnings Call Presentation (NYSE:SOLV) 2026-08-05 - Seeking Alpha
Earnings call transcript: Solventum tops Q2 2026 estimates, lifts outlook - Investing.com
Solventum Q2 FY26 slides: organic growth hits 9.5%, guidance raised - Investing.com
Activist pressure pushes Eagan-based Solventum to divest billion-dollar business - Star Tribune
Solventum Corporation reports results for the quarter ended June 30Earnings Summary - TradingView
Solventum beats estimates, raises guidance on strong growth - Investing.com
Solventum (NYSE:SOLV) Issues FY 2026 Earnings Guidance - MarketBeat
Solventum (SOLV) Q2 Earnings and Revenues Top Estimates - finance.yahoo.com
Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - finance.yahoo.com
Solventum Q2 2026 Earnings: 9.5% Organic Growth Supports Higher Guidance - TradingKey
Transcript : Solventum Corporation, Q2 2026 Earnings Call, Aug 05, 2026 - marketscreener.com
Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026 - finance.yahoo.com
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Solventum Corp-Aktie (SOLV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McMillan Wayde D. | Chief Financial Officer |
May 13 '26 |
Option Exercise |
0.00 |
9,503 |
0 |
53,041 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '26 |
Option Exercise |
0.00 |
3,960 |
0 |
22,130 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '26 |
Option Exercise |
0.00 |
2,376 |
0 |
7,632 |
| Kirberger Marcela A. | Chief Legal Affairs Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,488 |
0 |
15,492 |
| Hanson Bryan C | Chief Executive Officer |
May 13 '26 |
Option Exercise |
0.00 |
34,315 |
0 |
158,225 |
| Landucci Amy | Chief Information Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,422 |
0 |
41,905 |
| Wendell Amy McBride | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
10,422 |
| WEILAND JOHN H | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
| Mily Elizabeth | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
9,009 |
| Wilson Darryl L. | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
2.36%
0.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):